Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Susann M. Szmania"'
Autor:
Tarun K. Garg, Susann M. Szmania, Junaid A. Khan, Antje Hoering, Paul A. Malbrough, Amberly Moreno-Bost, Amy D. Greenway, Joshuah D. Lingo, Xin Li, Shmuel Yaccoby, Larry J. Suva, Brian Storrie, Guido Tricot, Dario Campana, John D. Shaughnessy, Bijay P. Nair, William T. Bellamy, Joshua Epstein, Bart Barlogie, Frits van Rhee
Publikováno v:
Haematologica, Vol 97, Iss 9 (2012)
Background Patients with gene expression profiling-defined high-risk myeloma in relapse have poor outcomes with current therapies. We tested whether natural killer cells expanded by co-culture with K562 cells transfected with 41BBL and membrane-bound
Externí odkaz:
https://doaj.org/article/43e308d104fa406da5162d5351f878a6
Autor:
Daniel E.H. Afar, Shmuel Yaccoby, Bart Barlogie, John D. Shaughnessy, Fenghuang Zhan, Audie G. Rice, Debra Chao, Bishwa Ganguly, Balaji Balasa, Rui Yun, Amberly M. Moreno-Bost, JuMei Shi, Tarun K. Garg, Mary K. Stone, Xin Li, Anne M. van Abbema, Myles Dillon, Susann M. Szmania, Frits van Rhee
Supplementary Data from Combinatorial efficacy of anti-CS1 monoclonal antibody elotuzumab (HuLuc63) and bortezomib against multiple myeloma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22ceb3c738108976650d682599b1dbd3
https://doi.org/10.1158/1535-7163.22486031
https://doi.org/10.1158/1535-7163.22486031
Autor:
Daniel E.H. Afar, Shmuel Yaccoby, Bart Barlogie, John D. Shaughnessy, Fenghuang Zhan, Audie G. Rice, Debra Chao, Bishwa Ganguly, Balaji Balasa, Rui Yun, Amberly M. Moreno-Bost, JuMei Shi, Tarun K. Garg, Mary K. Stone, Xin Li, Anne M. van Abbema, Myles Dillon, Susann M. Szmania, Frits van Rhee
Monoclonal antibody (mAb) therapy for multiple myeloma, a malignancy of plasma cells, has not been clinically efficacious in part due to a lack of appropriate targets. We recently reported that the cell surface glycoprotein CS1 (CD2 subset 1, CRACC,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ef3d3e9283c21d752107367ae7e8ce8
https://doi.org/10.1158/1535-7163.c.6532202
https://doi.org/10.1158/1535-7163.c.6532202
Autor:
Katie Stone, Emily Woods, Susann M Szmania, Owen W Stephens, Tarun K Garg, Bart Barlogie, John D Shaughnessy, Brett Hall, Manjula Reddy, Antje Hoering, Emily Hansen, Frits van Rhee
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e54610 (2013)
Multicentric Castleman Disease is largely driven by increased signaling in the pathway for the plasma cell growth factor interleukin-6. We hypothesized that interleukin-6/interleukin-6 receptor/gp130 polymorphisms contribute to increased interleukin-
Externí odkaz:
https://doaj.org/article/e3ad366ca5e447239d64c13d6fd64cf0